Jane Street Group, LLC Gilead Sciences, Inc. Put Options Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

Put Options

20 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$66.59 - $83.99 $10.4 Million - $13.1 Million	156,300 New	156,300 $13.1 Million
Q1 2022 May 17, 2022	BUY	$57.92 - $72.58 $1.95 Million - $2.45 Million	33,700 Added 2.6%	1,329,500 $79 Million
Q4 2021 Feb 15, 2022	BUY	$64.88 - $73.64 $30.5 Million - $34.6 Million	470,200 Added 56.95%	1,295,800 $94.1 Million
Q3 2021 Nov 16, 2021	BUY	$67.69 - $73.03 $23.5 Million - $25.4 Million	347,700 Added 72.76%	825,600 $57.7 Million
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $1.59 Million - $1.73 Million	25,000 Added 5.52%	477,900 $32.9 Million
Q1 2021 May 18, 2021	SELL	$60.0 - $68.46 $12.7 Million - $14.5 Million	-211,300 Reduced 31.81%	452,900 $29.3 Million
Q4 2020 Feb 17, 2021	SELL	$56.65 - $64.55 $17.7 Million - $20.2 Million	-312,600 Reduced 32.0%	664,200 $38.7 Million
Q3 2020 Nov 17, 2020	BUY	$62.1 - $78.08 $13.2 Million - $16.6 Million	212,700 Added 27.84%	976,800 $61.7 Million
Q2 2020 Aug 17, 2020	SELL	$72.34 - $84.0 $3.39 Million - $3.93 Million	-46,800 Reduced 5.77%	764,100 $58.8 Million
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $36.3 Million - $46.5 Million	579,800 Added 250.89%	810,900 $60.6 Million
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $2.74 Million - $3.02 Million	44,500 Added 23.85%	231,100 $15 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $2.04 Million - $2.26 Million	32,700 Added 21.25%	186,600 $11.8 Million
Q2 2019 Aug 15, 2019	BUY	$61.87 - $69.38 $6.66 Million - $7.47 Million	107,700 Added 233.12%	153,900 $10.4 Million
Q1 2019 May 16, 2019	SELL	$62.53 - $70.05 $1.66 Million - $1.86 Million	-26,600 Reduced 36.54%	46,200 $3 Million
Q4 2018 Feb 15, 2019	BUY	$60.54 - $79.0 $2.89 Million - $3.77 Million	47,700 Added 190.04%	72,800 $4.55 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $4.78 Million - $5.3 Million	-67,100 Reduced 72.78%	25,100 $1.94 Million
Q2 2018 Aug 15, 2018	SELL	$64.88 - $75.68 $1.56 Million - $1.82 Million	-24,000 Reduced 20.65%	92,200 $6.53 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $8.8 Million - $10.7 Million	-120,800 Reduced 50.97%	116,200 $8.76 Million
Q4 2017 Feb 15, 2018	BUY	$71.15 - $83.52 $1.49 Million - $1.75 Million	21,000 Added 9.72%	237,000 $17 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $15.6 Million - $18.5 Million	216,000	216,000 $17.5 Million

Others Institutions Holding GILD

# of Institutions

1,931

Shares Held

991M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$10.8 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.4 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$6.88 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.55 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.41 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account